Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melissa S Dillmon

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
AIDS Research and Human Retroviruses|October 13, 2005
Unusual thromboses associated with protein S deficiency in patients with acquired immunodeficiency syndrome: case reports and review of the literatureMelissa S Dillmon, Michael S Saag, Sate H Hamza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2017
Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: A Cancer Care Ontario and American Society of Clinical Oncology Clinical Practice GuidelineSukhbinder Dhesy-Thind, Glenn G Fletcher, Phillip S Blanchette, et al.
JCO Oncology Practice|May 27, 2025
Medically Integrated Dispensing Pharmacy: ASCO-Network for Collaborative Oncology Development & Advancement Standards UpdateLuis E Raez, Xylina T Gregg, Gurjyot K Doshi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2019
Patient-Centered Standards for Medically Integrated Dispensing: ASCO/NCODA StandardsMelissa S Dillmon, Erin B Kennedy, Mary K Anderson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 17, 2017
Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology-Cancer Care Ontario Focused Guideline UpdateCatherine Van Poznak, Mark R Somerfield, William E Barlow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 18, 2022
Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: ASCO-OH (CCO) Guideline UpdateAndrea Eisen, Mark R Somerfield, Melissa K Accordino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2021
Comparison of Radiation With or Without Concurrent Trastuzumab for HER2-Positive Ductal Carcinoma In Situ Resected by Lumpectomy: A Phase III Clinical TrialMelody A Cobleigh, Stewart J Anderson, Kalliopi P Siziopikou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 27, 2021
Differential Outcomes in Codon 12/13 and Codon 61 <i>NRAS</i>-Mutated Cancers in the Phase II NCI-MATCH Trial of Binimetinib in Patients with <i>NRAS</i>-Mutated TumorsJames M Cleary, Victoria Wang, Rebecca S Heist, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
AIDS Research and Human Retroviruses|October 13, 2005
Unusual thromboses associated with protein S deficiency in patients with acquired immunodeficiency syndrome: case reports and review of the literatureMelissa S Dillmon, Michael S Saag, Sate H Hamza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2017
Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: A Cancer Care Ontario and American Society of Clinical Oncology Clinical Practice GuidelineSukhbinder Dhesy-Thind, Glenn G Fletcher, Phillip S Blanchette, et al.
JCO Oncology Practice|May 27, 2025
Medically Integrated Dispensing Pharmacy: ASCO-Network for Collaborative Oncology Development & Advancement Standards UpdateLuis E Raez, Xylina T Gregg, Gurjyot K Doshi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2019
Patient-Centered Standards for Medically Integrated Dispensing: ASCO/NCODA StandardsMelissa S Dillmon, Erin B Kennedy, Mary K Anderson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 17, 2017
Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology-Cancer Care Ontario Focused Guideline UpdateCatherine Van Poznak, Mark R Somerfield, William E Barlow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 18, 2022
Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: ASCO-OH (CCO) Guideline UpdateAndrea Eisen, Mark R Somerfield, Melissa K Accordino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2021
Comparison of Radiation With or Without Concurrent Trastuzumab for HER2-Positive Ductal Carcinoma In Situ Resected by Lumpectomy: A Phase III Clinical TrialMelody A Cobleigh, Stewart J Anderson, Kalliopi P Siziopikou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 27, 2021
Differential Outcomes in Codon 12/13 and Codon 61 <i>NRAS</i>-Mutated Cancers in the Phase II NCI-MATCH Trial of Binimetinib in Patients with <i>NRAS</i>-Mutated TumorsJames M Cleary, Victoria Wang, Rebecca S Heist, et al.
Pageof 1